EP Biocomposites Ratios

EP Biocomposites Ltd Ratios

The EP Biocomposites Ltd Ratios page provides a complete fundamental analysis of EP Biocomposites Ltd using key valuation, profitability, and financial strength metrics. Investors tracking EP Biocomposites Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

EP Biocomposites Ltd (NSE: , BSE: 543595) is currently trading at ₹102.70, with a market capitalization of ₹0. As a major player in the Producer manufacturing sector and Industrial machinery industry, EP Biocomposites Ltd remains a key stock for fundamental analysis using EP Biocomposites Ltd Ratios.

EP Biocomposites Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The EP Biocomposites Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in EP Biocomposites Ltd Ratios.

Historically, the EP Biocomposites Ltd P/E ratio has shown strong fluctuations:

The decline in EP Biocomposites Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The EP Biocomposites Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

EP Biocomposites Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The EP Biocomposites Ltd P/S ratio currently stands at 0, an important part of EP Biocomposites Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining EP Biocomposites Ltd P/S ratio indicates cautious market sentiment.

EP Biocomposites Ltd Price to Cash Flow Ratio (P/CF)

The EP Biocomposites Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical EP Biocomposites Ltd Price to Cash Flow Ratio:

The declining EP Biocomposites Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

EP Biocomposites Ltd Enterprise Value Ratios

Enterprise Value (EV)

The EP Biocomposites Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

EP Biocomposites Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The EP Biocomposites Ltd EV/EBITDA ratio is currently 0, a key metric in EP Biocomposites Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable EP Biocomposites Ltd EV/EBITDA indicates balanced valuation.

EP Biocomposites Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The EP Biocomposites Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

EP Biocomposites Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The EP Biocomposites Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

EP Biocomposites Ltd Ratios Analysis Summary

The EP Biocomposites Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether EP Biocomposites Ltd stock is undervalued, fairly valued, or overvalued.

Tracking EP Biocomposites Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.